Tag Archives: Deal

BREAKING: Thumbs-up on $74B BMS-Celgene deal ends months of activist outrage

Bristol-Myers Squibb CEO Giovanni Caforio was less than 10 minutes into a special shareholders meeting on the company’s proposed $ 74 billion acquisition of Celgene when a broker interrupted his attempt to wrap up voting on the deal. “Are you going to address the dissenting votes?” he asked. “My family has owned tremendous quantities of… Read More »

GlaxoSmithKline's investors have come around on Tesaro deal, executive says

GlaxoSmithKline investors cheered when the company said it would finally spin off its consumer unit after swallowing Pfizer’s. But the company’s other December deal, for Tesaro, didn’t sit quite so well at first. When GSK first unveiled the $ 5.1 billion pact—which closed Tuesday—investors weren’t surprised that the company had made a move in pharma,… Read More »